MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia

Conclusions: MiR-181a-3p may be clinically useful as a disease marker for AML, and enhanced the prediction of patient outcomes to chemotherapy.

Source: Mediterranean Journal of Hematology and Infectious Diseases - February 26, 2020 Category: Hematology Authors: Xiaoling Ma Source Type: research